These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2455113)

  • 1. The central nervous system and effective antihypertensive effects of a calcium channel blocker.
    Takahashi H; Yoshimura M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S129-33. PubMed ID: 2455113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kidney and effective antihypertensive therapy.
    Hollenberg NK
    Am J Cardiol; 1985 Dec; 56(16):52H-55H. PubMed ID: 2866706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hypotensive effect of calcium antagonists and endogenous digitalis-like immunoreactivity in human essential hypertension.
    Palombo C; Marabotti C; Genovesi-Ebert A; Del Chicca MG; Balzan S; Giaconi S; Fommei E; Gazzetti P; Clerico A; Ghione S
    J Hypertens Suppl; 1986 Dec; 4(5):S461-4. PubMed ID: 3033184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented vasodepressor and sympathetic responses to intracerebroventricular injections of diltiazem, a calcium channel blocker, in DOCA-salt hypertensive rats.
    Takahashi H; Okabayashi H; Suga K; Iyoda I; Matsuzawa M; Ikegaki I; Yoshimura M; Ijichi H
    J Hypertens Suppl; 1986 Dec; 4(6):S156-9. PubMed ID: 3475411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive role of endogenous digoxin-like factor in rats with experimental hypertension.
    Pohlová I; Kunes J; Stolba P; Jelínek J; Zicha J
    Cor Vasa; 1986; 28(4):298-305. PubMed ID: 3021389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and sympathetic nerve activation: are there differences between classes?
    Noll G; Wenzel RR; Shaw S; Lüscher TF
    J Hypertens Suppl; 1998 Jan; 16(1):S17-24. PubMed ID: 9534092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of calcium antagonists in hypertension.
    Kiowski W; Bolli P; Erne P; Hulthén UL; Bühler FR
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S23-8. PubMed ID: 2455134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions and role of calcium entry blockers in hypertension: cardiac considerations.
    Sole MJ
    Clin Invest Med; 1989 Oct; 12(5):294-9. PubMed ID: 2689025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal parenchymal disease and hypertension.
    Preston RA; Epstein M
    Semin Nephrol; 1995 Mar; 15(2):138-51. PubMed ID: 7777724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digitalis-like substance discovered in human plasma.
    Brady SR
    Hawaii Med J; 1989 Mar; 48(3):97. PubMed ID: 2543651
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease.
    Mizuno Y; Jacob RF; Mason RP
    Am J Hypertens; 2008 Oct; 21(10):1076-85. PubMed ID: 18756260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein kinase C in the regulation of acetylcholine release in the central nervous system of spontaneously hypertensive rats.
    Tsuda K; Tsuda S; Nishio I
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S57-60. PubMed ID: 12688398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity.
    Kimura Y; Hirooka Y; Sagara Y; Sunagawa K
    Clin Exp Hypertens; 2007 Jan; 29(1):13-21. PubMed ID: 17190727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.